J&J strengthens R&D into COVID-19 vaccine with US government

Johnson & Johnson has announced it has expanded a collaboration with a US government agency to hasten development of its coronavirus vaccine, as fears mount about the scale of the outbr

NICE rejects J&J’s Spravato for treatment-resistant depressi...

Janssen's Darzalex approved in EU for newly-diagnosed multip...

Janssen’s Darzalex (daratumumab) has been approved in Europe as a combination therapy in newly-diagnosed patients with multiple myeloma.

J&J to buy US biotech Taris and its bladder cancer drug devi...

Johnson & Johnson is to buy the privately-owned biotech Taris, and a device that can deliver cancer drugs to the bladder.

Merck buys ArQule and BTK drug for $2.7bn

Merck & Co.

Janssen taps wearable tech in Invokana heart failure trial